🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and tolerability after ...
Status
Terminated
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00945425
GABA (gamma-aminobutyric acid) is the main inhibitory compound in the human...
Status
Completed
Location
National Hospital for Neurology and Neurosurgery, UCLH NHS Foundation Trust
Start Date
2014-09
Trial ID
NCT02135198
Treatments Being Tested
GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter in t...
Status
Completed
Location
National Hospital for Neurology and Neurosurgery
Start Date
2016-02
Trial ID
NCT02530580
Treatments Being Tested
This study will investigate the safety, tolerability and blood pharmacodyna...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2018-01-16
Trial ID
NCT03140813
Treatments Being Tested
This is a Phase I randomized double-blind, placebo-controlled, single centr...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00769899
This study investigates the brain response to a single acute dose of a GABA...
Status
Completed
Location
King's College London
Start Date
2018-12-07
Trial ID
NCT03678129
Treatments Being Tested
The purpose of this research study is to determine whether AstraZeneca's dr...
Status
Completed
Location
Research Site
Start Date
2008-12
Trial ID
NCT00808249
To determine the effects of repeated doses of AZD7325 on the pharmacokineti...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00790114
The purpose of the study is to determine the effects of the compound AZD732...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2008-06
Trial ID
NCT00720421
The purpose of this study is to examine the abuse potential of AZD7325....
Status
Completed
Location
Research Site
Start Date
2009-05
Trial ID
NCT00902772